KR101413094B1 - 항박테리아제로서의 퀴놀린 유도체 - Google Patents

항박테리아제로서의 퀴놀린 유도체 Download PDF

Info

Publication number
KR101413094B1
KR101413094B1 KR1020087005063A KR20087005063A KR101413094B1 KR 101413094 B1 KR101413094 B1 KR 101413094B1 KR 1020087005063 A KR1020087005063 A KR 1020087005063A KR 20087005063 A KR20087005063 A KR 20087005063A KR 101413094 B1 KR101413094 B1 KR 101413094B1
Authority
KR
South Korea
Prior art keywords
alkyl
formula
compound
compounds
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020087005063A
Other languages
English (en)
Korean (ko)
Other versions
KR20080039961A (ko
Inventor
코엔라드 요제프 로데비이크 마르셀 안드리스
아닐 코울
제롬 에밀 조지 귈레몽
엘리자베스 테레즈 쟌느 파스퀴어
Original Assignee
얀센 파마슈티카 엔.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35768115&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101413094(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 얀센 파마슈티카 엔.브이. filed Critical 얀센 파마슈티카 엔.브이.
Publication of KR20080039961A publication Critical patent/KR20080039961A/ko
Application granted granted Critical
Publication of KR101413094B1 publication Critical patent/KR101413094B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1020087005063A 2005-08-03 2006-07-31 항박테리아제로서의 퀴놀린 유도체 Active KR101413094B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05107155 2005-08-03
EP05107155.3 2005-08-03
PCT/EP2006/064847 WO2007014934A2 (en) 2005-08-03 2006-07-31 Quinoline derivatives as antibacterial agents

Publications (2)

Publication Number Publication Date
KR20080039961A KR20080039961A (ko) 2008-05-07
KR101413094B1 true KR101413094B1 (ko) 2014-07-01

Family

ID=35768115

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087005063A Active KR101413094B1 (ko) 2005-08-03 2006-07-31 항박테리아제로서의 퀴놀린 유도체

Country Status (30)

Country Link
US (1) US8691800B2 (enExample)
EP (1) EP1912649B1 (enExample)
JP (1) JP5208739B2 (enExample)
KR (1) KR101413094B1 (enExample)
CN (1) CN101277698B (enExample)
AP (1) AP2483A (enExample)
AR (1) AR054888A1 (enExample)
AU (1) AU2006274873B2 (enExample)
BR (1) BRPI0614099B8 (enExample)
CA (1) CA2615900C (enExample)
CY (1) CY1113535T1 (enExample)
DK (1) DK1912649T3 (enExample)
EA (1) EA014834B1 (enExample)
ES (1) ES2397358T3 (enExample)
HR (1) HRP20120910T1 (enExample)
IL (1) IL189140A (enExample)
JO (1) JO2837B1 (enExample)
ME (1) ME01485B (enExample)
MX (1) MX2008001601A (enExample)
MY (1) MY147637A (enExample)
NO (1) NO342328B1 (enExample)
NZ (1) NZ566012A (enExample)
PL (1) PL1912649T3 (enExample)
PT (1) PT1912649E (enExample)
RS (1) RS52606B (enExample)
SI (1) SI1912649T1 (enExample)
TW (1) TWI385168B (enExample)
UA (1) UA95911C2 (enExample)
WO (1) WO2007014934A2 (enExample)
ZA (1) ZA200801106B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2837B1 (en) 2005-08-03 2014-09-15 جانسن فارمسيتكا ان في Quinoline derivatives acting as antibacterial agents
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO3271B1 (ar) * 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
JP5246715B2 (ja) * 2009-01-27 2013-07-24 独立行政法人科学技術振興機構 蛋白質架橋阻害剤およびその用途
DK2841426T3 (en) 2012-04-27 2017-01-09 Janssen Pharmaceutica Nv ANTIBACTERIAL QUINOLIN DERIVATIVES
EA035443B1 (ru) 2012-04-27 2020-06-17 Янссен Фармацевтика Нв Антибактериальные хинолиновые производные
KR102355154B1 (ko) * 2016-03-07 2022-01-26 더 글로벌 얼라이언스 포 티비 드러그 디벨롭먼트, 잉크. 항박테리아 화합물 및 그의 용도

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004011436A1 (en) 2002-07-25 2004-02-05 Janssen Pharmaceutica N.V. Quinoline derivatives and their use as mycobacterial inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0936866A4 (en) * 1996-10-28 2001-04-11 Dept Of The Army Us Government Compounds, compositions and methods for treating antibiotic-resistant infections
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
TW200409637A (en) * 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
AP2188A (en) * 2004-01-23 2010-12-14 Janssen Pharmaceutica Nv Substituted quinolines and their use as mycobacterial inhibitors.
JO2837B1 (en) 2005-08-03 2014-09-15 جانسن فارمسيتكا ان في Quinoline derivatives acting as antibacterial agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004011436A1 (en) 2002-07-25 2004-02-05 Janssen Pharmaceutica N.V. Quinoline derivatives and their use as mycobacterial inhibitors

Also Published As

Publication number Publication date
AU2006274873A1 (en) 2007-02-08
SI1912649T1 (sl) 2013-01-31
CA2615900C (en) 2014-12-09
AR054888A1 (es) 2007-07-25
BRPI0614099B1 (pt) 2019-11-12
ES2397358T3 (es) 2013-03-06
HK1124232A1 (zh) 2009-07-10
EA200800513A1 (ru) 2008-06-30
UA95911C2 (ru) 2011-09-26
US20080227775A1 (en) 2008-09-18
ZA200801106B (en) 2009-09-30
MX2008001601A (es) 2008-02-19
IL189140A0 (en) 2008-08-07
IL189140A (en) 2014-07-31
CN101277698A (zh) 2008-10-01
PL1912649T3 (pl) 2013-03-29
BRPI0614099A2 (pt) 2011-03-09
TW200800971A (en) 2008-01-01
WO2007014934A8 (en) 2007-05-18
CA2615900A1 (en) 2007-02-08
EA014834B1 (ru) 2011-02-28
WO2007014934A3 (en) 2007-04-05
CN101277698B (zh) 2011-06-22
AU2006274873B2 (en) 2012-12-13
NO342328B1 (no) 2018-05-07
BRPI0614099B8 (pt) 2021-05-25
HRP20120910T1 (hr) 2012-12-31
ME01485B (me) 2014-04-20
AP2483A (en) 2012-10-01
WO2007014934A2 (en) 2007-02-08
JO2837B1 (en) 2014-09-15
US8691800B2 (en) 2014-04-08
JP2009503021A (ja) 2009-01-29
MY147637A (en) 2012-12-31
TWI385168B (zh) 2013-02-11
NO20081068L (no) 2008-02-29
EP1912649B1 (en) 2012-10-10
RS52606B (sr) 2013-04-30
CY1113535T1 (el) 2016-06-22
PT1912649E (pt) 2013-01-14
KR20080039961A (ko) 2008-05-07
NZ566012A (en) 2011-02-25
EP1912649A2 (en) 2008-04-23
JP5208739B2 (ja) 2013-06-12
DK1912649T3 (da) 2013-01-21

Similar Documents

Publication Publication Date Title
KR101337237B1 (ko) 항균제로서의 퀴놀린 유도체
KR101413997B1 (ko) 항균제로서의 퀴놀린 유도체
CN101232884B (zh) 作为抗菌剂的喹啉衍生物
JP5356246B2 (ja) 抗菌性キノリン誘導体
KR101413094B1 (ko) 항박테리아제로서의 퀴놀린 유도체
JP5466012B2 (ja) 抗菌性キノリン誘導体
JP5356245B2 (ja) 抗菌性キノリン誘導体
KR101329587B1 (ko) 항균제로서의 퀴놀린 유도체
KR101329585B1 (ko) 항균제로서 퀴놀린 유도체
KR101423229B1 (ko) 항박테리아제로서의 퀴놀린 유도체
KR101318181B1 (ko) 항균제로서의 퀴놀린 유도체
HK1124232B (en) Quinoline derivatives as antibacterial agents
BG109179A (bg) Хинолинови производни като антибактериални средства
HK1122210B (en) Quinoline derivatives as antibacterial agents
HK1120732B (en) Quinoline derivatives as antibacterial agents
HK1124234B (en) Quinoline derivatives as antibacterial agents
HK1120734B (en) Quinoline derivatives as antibacterial agents

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20080229

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20110729

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20130401

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20140203

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20130401

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20140502

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20140203

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20140611

Appeal identifier: 2014101002682

Request date: 20140502

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20140502

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20140502

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20130930

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20110729

Patent event code: PB09011R02I

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

Patent event date: 20140611

Comment text: Decision to Grant Registration

Patent event code: PB07012S01D

Patent event date: 20140603

Comment text: Transfer of Trial File for Re-examination before a Trial

Patent event code: PB07011S01I

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20140623

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20140624

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20170522

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20170522

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20180529

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20180529

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20190530

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20190530

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20220517

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20230518

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20240522

Start annual number: 11

End annual number: 11